ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,544.70
      0.72%
      US Tech 100
      19,231.40
      1.17%
      Dow Jones
      40,293.83
      0.02%
      Brent Oil
      81.305
      -1.18%
      Bitcoin
      67,320.92
      -1.23%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Catabasis Pharmaceuticals Inc (CATB)

      7. Catabasis Pharmaceuticals Inc (CATB) Financials

      Catabasis Pharmaceuticals Inc

      Catabasis Pharmaceuticals Inc (CATB)

      NASDAQ
      8.54
      0.00
      ( 0.00% )
      Updated: 20:00:00
      Delayed by 15 minutes

      Catabasis Pharmaceuticals Inc Financial Summary

      The current CATB market cap is 309.97M. The company's latest EPS is USD -2.0082 and P/E is -4.25.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -13.49M-15.1M-20.24M-34.2M-24.15M
      Net Income -11.19M-12.57M-17.73M-31.41M-19.93M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -27.09M-37.44M-194.98M-53.5M-83.03M
      Net Income -26.29M-37.3M-194.91M-51.83M-72.89M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 218.24M207.05M193.86M254.67M378.81M
      Total Liabilities 6.88M6.65M9.38M11.55M11.07M
      Total Equity 211.36M200.4M184.48M243.12M367.74M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 41.78M47.46M127.51M230.63M254.67M
      Total Liabilities 6.06M6.79M5.2M9.42M11.55M
      Total Equity 35.72M40.67M122.31M221.22M243.12M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -13.25M-23.95M-38.21M-68.45M-19.09M
      Investing 194.99M137.07M137.07M135.05M-126.23M
      Financing 37k310k420k88.4M141.81M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -26.57M-32.49M-30.15M-43.53M-68.45M
      Investing -4.08M6.3M-12.56M-167.13M135.05M
      Financing 25.62M40.86M104.28M144.72M88.4M

      Stats and Ratios

      Market Cap 309.97M
      Price to Earnings Ratio -4.25
      Price to Sales Ratio 0
      Price to Cash Ratio 1.77
      Price to Book Ratio 1.27
      Dividend Yield -

      Share Statistics

      Shares Outstanding 36.3M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 0.18 (2.09%)

      Company Info

      Company Name Catabasis Pharmaceuticals Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.astriatx.com
      Industry pharmaceutical preparations (2834)